Foam dressings for pressure injuries: a stage-by-stage guideline (NPIAP 1–4, unstageable, DTPI)

Key takeaway: Pressure injury stage tells you the depth of damage. Foam dressing choice should still be driven by exudate level, wound geometry, periwound condition, and offloading plan.

Key takeaways

Note: This guideline is for clinical education and protocol standardization. It does not replace facility policy or clinician judgment.

• Evidence scope: This guideline uses NPIAP pressure injury staging (2025) terminology and integrates selected evidence summaries (e.g., Cochrane) and clinical overviews (e.g., AAFP) for education and protocol standardization.

• Last updated: 2026-05-26

• Review cycle: Every 12 months (or earlier if major guideline updates occur)

• Disclosure: This content is for clinical education and protocol standardization only. It does not replace facility policy, clinician judgment, or individualized medical advice. Brand/product references (if any) are provided for informational procurement context only and do not imply superiority or guaranteed clinical outcomes.

• Use NPIAP staging consistently (Stage 1–4, Unstageable, DTPI). Staging helps describe tissue involvement and supports communication.

• Foam dressings are commonly used to absorb exudate, cushion tissue, and protect periwound skin. They’re not “one dressing for every stage.”

• For treating existing pressure injuries, evidence does not show foam dressings clearly heal faster than other advanced dressings, so selection should be practical and patient-specific. The Cochrane review found no clear superiority and rated the certainty very low.Cochrane review on foam dressings for treating pressure ulcers (2017)

• For prevention in high-risk patients, multilayer soft silicone foam dressings can be used as an adjunct over high-risk areas (especially sacrum and heels), alongside standard prevention measures.International Guideline: Preventive skin care (2025)

What foam dressings do and how they’re built (silicone foam dressing basics)

Foam dressings are designed to support moisture balance and protect tissue. Most foams share a similar architecture:

• Absorbent foam core (often polyurethane foam): takes up and holds exudate.

• Wound contact layer (may be nonadherent; in silicone foam dressings, often soft silicone): designed to reduce sticking and help minimize pain/trauma during dressing changes.

• Outer backing film (often semi-permeable): helps protect against external contamination while allowing moisture vapor to pass.

• Optional adhesive border (common in bordered silicone foam dressings): helps fixation without extra tape and can reduce edge lift when the skin is clean and dry.

A concise explainer of foam structure and function is available from Wounds International’s technology update PDF Understanding foam dressings.

What “clinical efficacy” realistically means for foam dressings

In daily practice, “efficacy” for a foam dressing often means it helps the team:

• control exudate and reduce maceration risk,

• protect periwound skin,

• reduce friction and shear at the skin surface,

• improve comfort and reduce dressing-change trauma,

• maintain a consistent care routine with fewer unplanned changes.

That’s different from claiming the dressing itself is proven to heal faster.

A Cochrane evidence review concluded there’s no clear evidence that foam dressings are more effective at healing pressure ulcers than other dressings, and the certainty of evidence is very low (see the Cochrane review linked above).

Before you choose a foam dressing: 6 checks that matter more than stage

Use stage to describe the injury, then run these checks to select (or rule out) foam:

1. Is the skin intact or open? Stage 1 and many DTPIs can be intact skin. That changes the goal from “absorb exudate” to “protect and monitor.”

2. What’s the exudate level? Foam is typically used when there’s some drainage to manage. A very dry wound often needs a different approach.

3. Is there undermining, tunneling, or dead space? Deep cavities often need a filler dressing plus a cover, rather than foam alone.

4. What’s happening to the periwound skin? Maceration, dermatitis, or fragile skin shifts the priority toward periwound protection and atraumatic fixation.

5. Where is the injury (and what’s the shape)? Sacrum, heel, trochanter, and device-related injuries behave differently. Fit matters.

6. What is the offloading plan? Repositioning and pressure redistribution remain foundational.AAFP: Pressure injuries—prevention, evaluation, and management (2023)

Stage-by-stage guideline: manifestations, symptoms, and foam dressing selection (pressure injury stages)

This section uses NPIAP-aligned staging language. For background on the staging revision, see the peer-reviewed summary Revised NPUAP pressure injury staging system (2016).

Facilities may use equivalent local terminology or national/international guidance; always follow local policy and documentation requirements.

For a practical clinical overview of evaluation and management fundamentals (including offloading and support surfaces), see AAFP’s 2023 review (linked earlier).

Stage 1 pressure injury (intact skin with non-blanchable erythema)

What you see

• Intact skin with localized non-blanchable erythema.

• In darker skin tones, color change may be subtle. Temperature, firmness, edema, or sensation changes may appear before clear redness.

What the patient may report (or what you may observe)

• Tenderness or pain.

• Area feels warmer or cooler than surrounding skin.

Where foam dressings fit

• There’s no open wound, so foam use here is typically protective/preventive, not exudate management.

• Consider a soft silicone foam as an adjunct over high-risk areas to reduce friction/shear and help with microclimate management, if the skin can tolerate it and the site can be inspected regularly.

Selection tips (if using foam prophylactically)

• Choose a size/shape that lays flat without wrinkles or edge roll.

• Build in daily under-dressing skin checks.

Escalate when

• Erythema expands, pain increases, blistering appears, or skin becomes purple/maroon (possible progression toward DTPI).

Stage 2 pressure injury (partial-thickness skin loss with exposed dermis)

What you see

• Partial-thickness loss with exposed dermis; wound bed is viable, pink/red, moist.

• May appear as an intact or ruptured serum-filled blister.

Associated symptoms

• Pain is common.

• Typically light exudate.

Foam dressing role

• Foam is commonly used when there is light to moderate exudate and you need cushioning and periwound protection.

• If the wound is minimally exudative and you need moisture donation, foam may be less helpful than other options.

How to select foam for Stage 2

• Prefer atraumatic contact (soft silicone contact layer) when pain, fragile skin, or MARSI risk is a concern.

• Use a border when it improves fixation and reduces tape use, but don’t force adhesive onto irritated or very fragile periwound skin.

Escalate when

• Exudate becomes heavy, odor develops, drainage turns purulent, discoloration becomes maroon/purple, or pain worsens.

Stage 3 pressure injury (full-thickness skin loss, adipose visible)

What you see

• Full-thickness skin loss; adipose is visible.

• Granulation tissue and epibole are often present.

• Slough/eschar may be visible.

• Undermining/tunneling may occur.

Associated symptoms

• Drainage may be moderate to heavy.

• Pain varies (may be reduced in sensory impairment).

Foam dressing role

• Foam can be a good fit when drainage is manageable and the wound is shallow enough that foam can contact and protect without leaving dead space.

• For deeper cavities, consider a filler dressing (selected by the clinical team) plus foam as a secondary cover if appropriate.

How to select foam for Stage 3

• Match absorption to drainage, not to stage.

• Prioritize periwound protection if there’s maceration.

• If wear time goals are driving selection, be explicit: fewer changes only works if the dressing can handle the exudate load without leakage.

Escalate when

• Rapid increase in exudate, foul odor, spreading erythema, systemic symptoms, or new exposed/deep structures.

Stage 4 pressure injury (full-thickness skin and tissue loss, deeper structures exposed)

What you see

• Full-thickness loss with exposed or directly palpable fascia, muscle, tendon, ligament, cartilage, or bone.

• Undermining and tunneling are common.

Associated symptoms

• Drainage often moderate to copious.

• Pain may be severe or unexpectedly mild in neuropathy.

Foam dressing role

• Foam is often not sufficient as a stand-alone primary dressing because stage 4 injuries frequently require dead-space management, debridement planning, and high-capacity exudate control.

• Foam may be used as a secondary cover or to protect surrounding skin, depending on the overall plan.

Escalate when

• Concern for bone involvement, systemic illness, uncontrolled pain, or rapidly worsening drainage.

Unstageable pressure injury (base obscured by slough/eschar)

What you see

• Full-thickness skin and tissue loss, but the true depth is obscured by slough and/or eschar.

Associated symptoms

• Variable pain and exudate.

• Odor and increased drainage can occur when there’s heavy bioburden or infection.

Foam dressing role

• Foam may be appropriate when there is exudate to manage and you need a protective cover, but the care plan often focuses on clinician-directed decisions about debridement and infection control.

Escalate when

• Increasing odor, drainage, erythema, fluctuance, systemic symptoms, or concern for ischemia.

Deep tissue pressure injury (DTPI)

What you see

• Persistent, non-blanchable deep red, maroon, or purple discoloration.

• May present as an intact or blood-filled blister.

• Can evolve rapidly.

Associated symptoms

• Pain and temperature change can precede visible discoloration.

• Tissue may feel boggy, firm, warmer, or cooler than adjacent skin.

Foam dressing role

• DTPI management is primarily about rapid offloading and close monitoring. A protective silicone foam may be used to reduce friction and manage microclimate, but it should not delay escalation or replace offloading.

For DTPI evolution and why surface changes may lag deeper injury, see NPIAP: Evolution of Deep Tissue Pressure Injury (2021).

Escalate when

• Discoloration expands, blistering develops, skin sloughing begins, or pain increases.

Quick reference: foam dressings for pressure injuries by stage

Common failure modes: why foam “doesn’t work” in practice

• Using absorption that’s too low for the exudate load, leading to leakage and maceration.

• Poor fit on anatomy (edge roll, bridging, shear under the dressing), especially sacrum/heel.

• Inconsistent offloading, where the dressing is asked to compensate for pressure/shear.

• Tape-heavy fixation on fragile skin, increasing MARSI risk.

• Treating stage as the only input and ignoring depth/geometry, undermining, and periwound condition.

Video: prophylactic silicone foam in pressure injury prevention

Where SLK Medical fits

SLK Medical manufactures advanced wound care dressings, including silicone foam dressings. If your team is standardizing foam use across units, the practical goal is less about “which brand is best” and more about making sure your selected foam options cover:

• the absorption range you actually see (light through heavy exudate),

• anatomical fit needs (sacrum, heel, other prominences),

• skin fragility / MARSI risk,

• training simplicity (clear, stage-agnostic selection rules).

Next steps (procurement-grade)

If you’re building or refreshing a pressure injury dressing protocol, request a spec sheet and IFU pack and align it to your internal indications (exudate ranges, wear time expectations, and skin-check frequency). Then pilot with a short, documented in-service plan so stage documentation and dressing selection stay consistent.